Redpoint Investment Management Pty LTD Neurocrine Biosciences Inc Transaction History
Redpoint Investment Management Pty LTD
- $684 Million
- Q3 2022
A detailed history of Redpoint Investment Management Pty LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 3,662 shares of NBIX stock, worth $450,535. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,662
Previous 5,088
28.03%
Holding current value
$450,535
Previous $496,000
21.57%
% of portfolio
0.06%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.2MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.22 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$681 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$598 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$329 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...